ArticleMolecular oncology2022

A novel anti-c-Kit antibody-drug conjugate to treat wild-type and activating-mutant c-Kit-positive tumors.

Jin-Ock Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.